info@targetmol.com    Tel: (857) 239-0968 / (617) 419-7131
Home > PLK
PLK
Cat.No. Product Name Information Area
T6282 GSK461364 GSK461364 inhibits purified Plk1 with Ki of 2.2 nM. It is more than 1000-fold selecti... Cancer
T6247 NMS-P937 (NMS1286937) NMS-P937 (NMS1286937) is an orally available, selective Polo-like Kinase 1 (PLK1) inh... Cancer
T6173 BI 2536 BI2536 is a potent Plk1 inhibitor with IC50 of 0.83 nM. It shows 4- and 11-fold great... Cancer
T6070 Rigosertib (ON-01910) Rigosertib (ON-01910) is a non-ATP-competitive inhibitor of PLK1 with IC50 of 9 nM. I... Cancer
T6019 Volasertib (BI 6727) Volasertib (BI 6727) is a highly potent Plk1 inhibitor with IC50 of 0.87 nM. It shows... Cancer
T2704 MLN0905 MLN0905 is a potent inhibitor of PLK1 with IC50 of 2 nM. Cancer
T2634 Ro3280 RO3280 is a potent, highly selective inhibitor of Polo-like kinase 1 (PLK1) with IC50... Cancer
T2438 HMN-214 HMN-214(IVX214) is a potent PLK1 inhibitor an average IC50 of 0.12 μM. Cancer
T2271 SBE13 Hydrochloride SBE13 hydrochloride is a potent and selective PLK1 with IC50 of 0.2 nM; no inhibition... Other
T0973 Pyridoxine Pyridoxine is the 4-methanol form of vitamin B6 and is converted to pyridoxal 5-phosp... Nervous system
1